Detalhe da pesquisa
1.
[SLAM family proteins as therapeutic targets in multiple myeloma].
Rinsho Ketsueki
; 61(7): 818-826, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-32759570
2.
Contradictory intrahepatic immune responses activated in high-load hepatitis C virus livers compared with low-load livers.
Arch Virol
; 163(4): 855-865, 2018 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29248968
3.
Transmembrane serine protease TMPRSS2 activates hepatitis C virus infection.
Hepatology
; 61(2): 437-46, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25203900
4.
[Evaluation of the enhanced International Prognostic Index (NCCN-IPI) for cases with diffuse large B-cell lymphoma].
Rinsho Ketsueki
; 56(7): 915-8, 2015 Jul.
Artigo
em Japonês
| MEDLINE | ID: mdl-26256931
5.
CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
Arch Virol
; 159(11): 2949-55, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24965233
6.
ß-Glucuronidase is a suitable internal control gene for mRNA quantitation in pathophysiological and non-pathological livers.
Exp Mol Pathol
; 95(2): 131-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23769876
7.
Current and Future PET Imaging for Multiple Myeloma.
Life (Basel)
; 13(8)2023 Aug 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37629558
8.
The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.
Exp Hematol
; 121: 38-47.e2, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36796620
9.
Epigenetic Priming with Decitabine Augments the Therapeutic Effect of Cisplatin on Triple-Negative Breast Cancer Cells through Induction of Proapoptotic Factor NOXA.
Cancers (Basel)
; 14(1)2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35008411
10.
Clinicopathologic Characteristics and A20 Mutation in Primary Thyroid Lymphoma.
J Nippon Med Sch
; 89(3): 301-308, 2022 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34840214
11.
Immune Functions of Signaling Lymphocytic Activation Molecule Family Molecules in Multiple Myeloma.
Cancers (Basel)
; 13(2)2021 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33451089
12.
Durvalumab Combined with Immunomodulatory Drugs (IMiD) Overcomes Suppression of Antitumor Responses due to IMiD-induced PD-L1 Upregulation on Myeloma Cells.
Mol Cancer Ther
; 20(7): 1283-1294, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33879556
13.
2',5'-Oligoadenylate synthetase-like gene highly induced by hepatitis C virus infection in human liver is inhibitory to viral replication in vitro.
Biochem Biophys Res Commun
; 392(3): 397-402, 2010 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-20074559
14.
PD-L1-PD-1 Pathway in the Pathophysiology of Multiple Myeloma.
Cancers (Basel)
; 12(4)2020 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32290052
15.
The SLAMF3 rs509749 polymorphism correlates with malignant potential in multiple myeloma.
Exp Hematol
; 90: 72-79, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32818503
16.
SLAMF3-Mediated Signaling via ERK Pathway Activation Promotes Aggressive Phenotypic Behaviors in Multiple Myeloma.
Mol Cancer Res
; 18(4): 632-643, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31974290
17.
Immunotherapy for Multiple Myeloma.
Cancers (Basel)
; 11(12)2019 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842518
18.
Clinical impact of serum soluble SLAMF7 in multiple myeloma.
Oncotarget
; 9(78): 34784-34793, 2018 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30410677
19.
Functional expression of Tim-3 on blasts and clinical impact of its ligand galectin-9 in myelodysplastic syndromes.
Oncotarget
; 8(51): 88904-88917, 2017 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-29179486
20.
Histone deacetylase inhibitor panobinostat induces calcineurin degradation in multiple myeloma.
JCI Insight
; 1(5): e85061, 2016 04 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-27699258